Changes in mortality and causes of death in the Swedish Down syndrome population

American Journal of Medical Genetics, Part A

Volumn 161, Issue 4, 2013, Pages 642-649

  Englund, Annika ^a   Jonsson, Björn ^a   Zander, Cecilia Soussi ^a   Gustafsson, Jan ^a   Annerén, Göran ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

Causes of death; Down syndrome; Epidemiology; Morbidity; Mortality; Trends

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ATHEROSCLEROSIS; CAUSE OF DEATH; CENTRAL NERVOUS SYSTEM DISEASE; CHILD; CHILDHOOD LEUKEMIA; CONGENITAL HEART DISEASE; DEMENTIA; DOWN SYNDROME; EPILEPSY; FEMALE; GASTROINTESTINAL DISEASE; HUMAN; INFANT; ISCHEMIC HEART DISEASE; MALE; MORTALITY; PNEUMONIA; PRESCHOOL CHILD; PRIORITY JOURNAL; REGISTER; SCHOOL CHILD; SOLID TUMOR; SWEDEN;

ADOLESCENT; ADULT; AGE FACTORS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; DOWN SYNDROME; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; REGISTRIES; SWEDEN; YOUNG ADULT;

EID: 84875523720     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.35706     Document Type: Article

References (33)

1. Baird PA, Sadovnick AD. 1987. Life expectancy in Down syndrome. J Pediatr 110:849-854.
2. Bull MJ. 2011. Health supervision for children with Down syndrome. Pediatrics 128:393-406.
3. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, Mullan M. 1991. Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-amyloid precursor protein gene. Nature 353:844-846.
4. Cnattingius S, Zack M, Ekbom A, Gunnarskog J, Linet M, Adami HO. 1995a. Prenatal and neonatal risk factors for childhood myeloid leukemia. Cancer Epidemiol Biomarkers Prev 4:441-445.
5. Cnattingius S, Zack MM, Ekbom A, Gunnarskog J, Kreuger A, Linet M, Adami HO. 1995b. Prenatal and neonatal risk factors for childhood lymphatic leukemia. J Natl Cancer Inst 87:908-914.
6. Cocchi G, Gualdi S, Bower C, Halliday J, Jonsson B, Myrelid A, Mastroiacovo P, Amar E, Bakker MK, Correa A, Doray B, Melve KK, Koshnood B, Landau D, Mutchinick OM, Pierini A, Ritvanen A, Ruddock V, Scarano G, Sibbald B, Sipek A, Tenconi R, Tucker D, Anneren G. 2010. International trends of Down syndrome 1993-2004: Births in relation to maternal age and terminations of pregnancies. Birth Defects Res A Clin Mol Teratol 88:474-479.
7. Coppus A, Evenhuis H, Verberne GJ, Visser F, van Gool P, Eikelenboom P, van Duijin C. 2006. Dementia and mortality in persons with Down's syndrome. J Intellect Disabil Res 50:768-777.
8. Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. 2005. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol 47:171-176.
9. Forssman H, Akesson HO. 1965. Mortality in patients with Down's syndrome. J Ment Defic Res 9:146-149.
10. Frid C, Drott P, Lundell B, Rasmussen F, Anneren G. 1999. Mortality in Down's syndrome in relation to congenital malformations. J Intellect Disabil Res 43:234-241.
11. Frid C, Bjorkhem G, Jonzon A, Sunnegardh J, Anneren G, Lundell B. 2004. Long-term survival in children with atrioventricular septal defect and common atrioventricular valvar orifice in Sweden. Cardiol Young 14:24-31.
12. Glasson EJ, Sullivan SG, Hussain R, Petterson BA, Montgomery PD, Bittles AH. 2002. The changing survival profile of people with Down's syndrome: Implications for genetic counselling. pp 390-393.
13. Goldacre MJ, Wotton CJ, Seagroatt V, Yeates D. 2004. Cancers and immune related diseases associated with Down's syndrome: A record linkage study. Arch Dis Child 89:1014-1017.
14. Hasle H, Clemmensen IH, Mikkelsen M. 2000. Risks of leukaemia and solid tumours in individuals with Down's syndrome. Lancet 355:165-169.
15. Hermon C, Alberman E, Beral V, Swerdlow AJ. 2001. Mortality and cancer incidence in persons with Down's syndrome, their parents and siblings. Ann Hum Genet 65:167-176.
16. Hill DA, Gridley G, Cnattingius S, Mellemkjaer L, Linet M, Adami HO, Olsen JH, Nyren O, Fraumeni JF Jr. 2003. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 163:705-711.
17. Irving CA, Chaudhari MP. 2011. Cardiovascular abnormalities in Down's syndrome: Spectrum, management and survival over 22 years. Arch Dis Child 97:326-330.
18. Leoncini E, Botto LD, Cocchi G, Anneren G, Bower C, Halliday J, Amar E, Bakker MK, Bianca S, Canessa Tapia MA, Castilla EE, Csáky-Szunyogh M, Dastgiri S, Feldkamp ML, Gatt M, Hirahara F, Landau D, Lowry RB, Marengo L, McDonnell R, Mathew TM, Morgan M, Mutchinick OM, Pierini A, Poetzsch S, Ritvanen A, Scarano G, Siffel C, Sípek A, Szabova E, Tagliabue G, Vollset SE, Wertelecki W, Zhuchenko L, Mastroiacovo P. 2010. How valid are the rates of Down syndrome internationally? Findings from the International Clearinghouse for Birth Defects Surveillance and Research. Am J Med Genet Part A 152A:1670-1680.
19. Licastro F, Marocchi A, Penco S, Porcellini E, Lio D, Dogliotti G, Corsi MM. 2006. Does Down's syndrome support the homocysteine theory of atherogenesis? Experience in elderly subjects with trisomy 21. Arch Gerontol Geriatr 43:381-387.
20. Margallo-Lana ML, Moore PB, Kay DW, Perry RH, Reid BE, Berney TP, Tyrer SP. 2007. Fifteen-year follow-up of 92 hospitalized adults with Down's syndrome: Incidence of cognitive decline, its relationship to age and neuropathology. J Intellect Disabil Res 51:463-477.
21. Miettinen OS, Wang JD. 1981. An alternative to the proportionate mortality ratio. Am J Epidemiol 114:144-148.
22. Nirje B. 1969. The normalization principle and its human management implications. In: Kugel R, Wolfensberger W, editors. Changing patterns in residentiol services for the mentally retarded. Washington DC: President's Committee on Mental Retardation.
23. Patja K, Pukkala E, Sund R, Iivanainen M, Kaski M. 2006. Cancer incidence of persons with Down syndrome in Finland: A population-based study. Int J Cancer 118:1769-1772.
24. Pueschel SM, Anneren G, Durlach R, Flores J, Sustrova M, Verma IC. 1995. Guidelines for optimal medical care of persons with Down syndrome. International League of Societies for Persons with Mental Handicap (ILSMH). Acta Paediatr 84:823-827.
25. Ram G, Chinen J. 2011. Infections and immunodeficiency in Down syndrome. Clin Exp Immunol 164:9-16.
26. Rothman KJGS. 1998. Modern epidemiology. Philadelphia: Lippincott Williams & Wilkins.
27. Satge D, Sommelet D, Geneix A, Nishi M, Malet P, Vekemans M. 1998. A tumor profile in Down syndrome. Am J Med Genet 78:207-216.
28. SBU. 2006. Methods of early prenatal diagnosis. The Swedish Council on Technology Assessment in Health Care. Report nr 182. pp 1-36.
29. Skotko BG, Kishnani PS, Capone GT. 2009. Prenatal diagnosis of Down syndrome: How best to deliver the news. Am J Med Genet Part A 149A:2361-2367.
30. Sussan TE, Yang A, Li F, Ostrowski MC, Reeves RH. 2008. Trisomy represses Apc(Min)-mediated tumours in mouse models of Down's syndrome. Nature 451:73-75.
31. Taketani T, Taki T, Takita J, Tsuchida M, Hanada R, Hongo T, Kaneko T, Manabe A, Ida K, Hayashi Y. 2003. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies. Genes Chromosomes Cancer 38:1-7.
32. Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM. 2009. Down syndrome-Recent progress and future prospects. Hum Mol Genet 18:R75-R83.
33. Yang Q, Rasmussen SA, Friedman JM. 2002. Mortality associated with Down's syndrome in the USA from 1983 to 1997: A population-based study. Lancet 359:1019-1025.